EmphyClear Oral Spray (sodium pyruvate) / EmphyCorp - LARVOL DELTA

Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis. (PubMed, J Aerosol Med Pulm Drug Deliv) - " The intranasal administration of sodium pyruvate significantly improved nasal inflammation scores in all five clinical trials of patients with AR (p < 0.0001 in all trials). These results give credence to the overall ability of sodium pyruvate, administered by nasal spray, to treat inflammation of the nasal airways."

Journal • Allergic Rhinitis • Immunology • Inflammation • Respiratory Diseases • CCL2 • CXCL8 • IL6

Sodium Pyruvate Inhalation for COVID-19 Long Hauler Symptoms – An Effective and Inexpensive Treatment (IMMUNOLOGY 2022) - "This study examined the effects of N115 treatment on the symptoms associated with COVID-19 long haulers. We have observed significant improvement in SaO2 levels, trouble breathing and fewer headaches indicating that N115 is a potential therapeutic for a major disease with few current options for treatment."

Chronic Obstructive Pulmonary Disease • Fatigue • Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Infectious Disease • Novel Coronavirus Disease • Pain • Pulmonary Disease • Respiratory Diseases